Paper Details

  1. Home
  2. Paper Details

Z-drug for schizophrenia: A systematic review and meta-analysis.

Author: InadaKen, IwataNakao, KishiTaro, MatsuiYuki

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This meta-analysis investigated the efficacy and safety of Z-drugs for the treatment of schizophrenia. The meta-analysis showed no significant differences in any outcome between pooled Z-drug and placebo treatment groups. However, one study showed that eszopiclone was superior to placebo in improving the Insomnia Severity Index scores.
Paper Details　
Original Abstract of the Article :
No systematic reviews and meta-analyses on the use of Z-drug for schizophrenia are available. Randomized, placebo-controlled, or non-pharmacological intervention-controlled trials published before 03/20/2017 were retrieved from major healthcare databases and clinical trial registries. A meta-analysi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.psychres.2017.06.063

データ提供：米国国立医学図書館（NLM）

Z-Drugs for Schizophrenia: A Search for Relief

Schizophrenia is a complex mental illness that can be a challenging journey for those who experience it. This research investigates the use of Z-drugs, a class of sleep medications, for treating schizophrenia. It's like exploring a new path in the vast desert of mental health treatment, seeking a more effective way to alleviate symptoms.

The researchers conducted [research methods] to assess the effectiveness and safety of Z-drugs in patients with schizophrenia. While the meta-analysis did not find significant overall benefits, some individual studies suggest potential for short-term use in treating insomnia.

A New Path in the Desert of Schizophrenia

The study indicates that Z-drugs, while not a complete solution, may offer some benefit for specific aspects of schizophrenia, like sleep disturbances. It's like discovering a new oasis in the desert of mental health treatment, offering a potential source of relief for some patients.

Navigating the Challenges of Schizophrenia

This research underscores the need for ongoing research to find more effective treatments for schizophrenia. It's like navigating a challenging desert landscape, searching for a path to recovery. By exploring new avenues and understanding the complexities of this illness, we can provide better care for those who are affected by it.

Dr.Camel's Conclusion

This study offers a glimpse into the potential use of Z-drugs for treating schizophrenia, specifically for improving sleep quality. It reminds us that the journey toward understanding and treating mental illness is a continuous one, requiring ongoing exploration and discovery.

Date :
  1. Date Completed 2018-05-02
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28686934

DOI: Digital Object Identifier

10.1016/j.psychres.2017.06.063

Related Literature

Article Analysis
・Effects of eszopiclone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.